FDA notifications. Roche issues letter about saquinavir.
D004304:Dosage Forms; D004345:Drug Industry; D015658:HIV Infections / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000008:administration & dosage; D006801:Humans; D019258:Saquinavir / Q000008:administration & dosage
D004304:Dosage Forms; D017320:HIV Protease Inhibitors; D019258:Saquinavir